Q1 2026 earnings call insights: sales up 6%, guidance intact, tariff update, Unity & Tryptyr traction, and $1.5B buyback—read now.

By Simon Ferdinand Eibach Gdansk, May 6 (Reuters) - Swiss-American eye care company Alcon reported a 10% rise in its quarterly revenue, citing recent product launches as main drivers. • Alcon's net ...

Alcon shares fell around 7% on Wednesday after the Swiss eye care company reported first-quarter sales that fell short of analyst expectations, even as it raised its full-year earnings outlook.

Alcon reported a 10% year-on-year rise in quarterly revenue to $2.69 billion, driven by 10 new product launches, including next-generation cataract lenses. Operating earnings fell 32% to $292 million, ...

In the U.S., Alcon gained approximately 2 share points in the PC-IOL category, driven by the PanOptix Pro trifocal lens and ...

Alcon ALC recently announced the U.S. launch of Clareon TruPlus, its newly enhanced monofocal and toric intraocular lens (IOL). It was introduced at the American Society of Cataract and Refractive ...

Alcon AG reports first-quarter earnings Tuesday after the close, testing whether the Swiss eye-care giant’s recent wave of product launches can sustain double-digit growth momentum even as analyst ...

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ...

Centurion Service Group, an industry-leading medical equipment lifecycle organization, in partnership with Auction Advisors, LLC, a premier auction and liquidation firm, today announced a major online ...

Why Alcon (SWX:ALC) is on investors’ radar today Alcon (SWX:ALC) has drawn attention after recent trading left the stock with a year-to-date return of about an 8% decline and a one-year total return ...